Samy Tadros
Corporate Officer/Principal bei TANGO THERAPEUTICS, INC.
Profil
Samy Tadros is currently the Head of Business Development at Tango Therapeutics, Inc. He previously worked as the Executive Director of Business Development at Celgene Corp.
Tadros has an undergraduate degree from Concordia University Chicago, an MBA from Fairleigh Dickinson University, and a graduate degree from Temple University School of Pharmacy.
Aktive Positionen von Samy Tadros
| Unternehmen | Position | Beginn |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Samy Tadros
| Unternehmen | Position | Ende |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
Ausbildung von Samy Tadros
| Concordia University Chicago | Undergraduate Degree |
| Temple University School of Pharmacy | Graduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TANGO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
